Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Buy
70
BHF Quote, Financials, Valuation and Earnings
Last price:
$58.01
Seasonality move
:
6.83%
Day range:
$57.15 - $58.61
52-week range:
$40.00 - $64.12
Dividend yield:
0%
P/E ratio:
11.24x
P/S ratio:
--
P/B ratio:
0.68x
Volume:
865.8K
Avg. volume:
843K
1-year change:
18.01%
Market cap:
$3.4B
Revenue:
$4.4B
EPS (TTM):
$5.16
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.3B | $3.6B | $6.6B | $4B | $4.4B | |
| Revenue Growth (YoY) | 30.65% | -56.63% | 84.94% | -40.42% | 10.61% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $627M | $665M | $647M | $730M | $693M | |
| Other Inc / (Exp) | $413M | $450M | $478M | $483M | $579M | |
| Operating Expenses | $1.7B | $1.7B | $1.5B | $1.5B | $1.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $227M | $238M | $153M | $153M | $152M | |
| EBT. Incl. Unusual Items | -$1.4B | $2B | $4.7B | -$1.5B | $422M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$363M | $361M | $848M | -$367M | $29M | |
| Net Income to Company | -$1.1B | $1.6B | $3.9B | -$1.1B | $393M | |
| Minority Interest in Earnings | -$5M | -$5M | -$5M | -$5M | -$5M | |
| Net Income to Common Excl Extra Items | -$1.1B | $1.6B | $3.9B | -$1.1B | $388M | |
| Basic EPS (Cont. Ops) | -$11.58 | $18.54 | $51.73 | -$18.39 | $4.67 | |
| Diluted EPS (Cont. Ops) | -$11.58 | $18.39 | $51.30 | -$18.39 | $4.64 | |
| Weighted Average Basic Share | $95.4M | $83.8M | $73M | $66M | $61.2M | |
| Weighted Average Diluted Share | $95.4M | $84.5M | $73.6M | $66M | $61.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$1.2B | $2.2B | $4.9B | -$1.3B | $574M | |
| Revenue (Reported) | $8.3B | $3.6B | $6.6B | $4B | $4.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$1.2B | $2.2B | $4.9B | -$1.3B | $574M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -$62M | -$450M | -$134M | $1.4B | $1.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -20.93% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $178M | $184M | $196M | $207M | $172M | |
| Other Inc / (Exp) | $119M | $105M | $100M | $135M | $150M | |
| Operating Expenses | $468M | $457M | $357M | $396M | $351M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $88M | $116M | $39M | $39M | $38M | |
| EBT. Incl. Unusual Items | -$1.3B | $2.3B | $40M | -$1.2B | $834M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$275M | $451M | -$97M | -$258M | $162M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$1M | -$1M | -$1M | -$1M | -$1M | |
| Net Income to Common Excl Extra Items | -$1B | $1.8B | $136M | -$917M | $671M | |
| Basic EPS (Cont. Ops) | -$11.85 | $0.54 | $1.61 | -$14.83 | $11.02 | |
| Diluted EPS (Cont. Ops) | -$11.85 | $0.51 | $1.59 | -$14.83 | $10.79 | |
| Weighted Average Basic Share | $89.3M | $79.4M | $69M | $64.1M | $59.2M | |
| Weighted Average Diluted Share | $89.3M | $82.1M | $70M | $64.1M | $60.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$1.3B | $2.3B | $79M | -$1.1B | $872M | |
| Revenue (Reported) | -$62M | -$450M | -$134M | $1.4B | $1.1B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$1.3B | $2.3B | $79M | -$1.1B | $872M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.3B | $3.9B | $6.6B | $4B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $627M | $665M | $647M | $730M | $693M | |
| Other Inc / (Exp) | $413M | $450M | $478M | $483M | $579M | |
| Operating Expenses | $1.7B | $1.7B | $1.5B | $1.5B | $1.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $227M | $238M | $153M | $153M | $152M | |
| EBT. Incl. Unusual Items | -$1.4B | $2B | $4.7B | -$1.5B | $422M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$363M | $361M | $848M | -$367M | $29M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$5M | -$5M | -$5M | -$5M | -$5M | |
| Net Income to Common Excl Extra Items | -$1.1B | $1.6B | $3.9B | -$1.1B | $388M | |
| Basic EPS (Cont. Ops) | -$18.18 | -$1.93 | $50.34 | -$18.64 | $5.41 | |
| Diluted EPS (Cont. Ops) | -$18.33 | -$2.00 | $50.00 | -$18.67 | $5.16 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$1.2B | $2.2B | $4.9B | -$1.3B | $574M | |
| Revenue (Reported) | $8.3B | $3.9B | $6.6B | $4B | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$1.2B | $2.2B | $4.9B | -$1.3B | $574M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.9B | $6.6B | $4B | $4.4B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $665M | $647M | $730M | $693M | -- | |
| Other Inc / (Exp) | $450M | $478M | $483M | $579M | -- | |
| Operating Expenses | $1.7B | $1.5B | $1.5B | $1.4B | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $238M | $153M | $153M | $152M | -- | |
| EBT. Incl. Unusual Items | $2B | $4.7B | -$1.5B | $422M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $361M | $848M | -$367M | $29M | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$5M | -$5M | -$5M | -$5M | -- | |
| Net Income to Common Excl Extra Items | $1.6B | $3.9B | -$1.1B | $388M | -- | |
| Basic EPS (Cont. Ops) | -$1.93 | $50.34 | -$18.64 | $5.41 | -- | |
| Diluted EPS (Cont. Ops) | -$2.00 | $50.00 | -$18.67 | $5.16 | -- | |
| Weighted Average Basic Share | $335.2M | $291.9M | $264.1M | $244.8M | -- | |
| Weighted Average Diluted Share | $339M | $294.4M | $264.4M | $247.1M | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.2B | $4.9B | -$1.3B | $574M | -- | |
| Revenue (Reported) | $3.9B | $6.6B | $4B | $4.4B | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.2B | $4.9B | -$1.3B | $574M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.1B | $4.5B | $4.1B | $3.9B | $5B | |
| Short Term Investments | $85.7B | $89.4B | $76.7B | $82.2B | $81.9B | |
| Accounts Receivable, Net | $16.2B | $16.1B | $18.5B | $19.8B | $21.1B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $106B | $110B | $99.4B | $105.8B | $108.1B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $88.7B | $93.8B | $81.5B | $87.2B | $86.8B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $504M | $530M | $459M | $416M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $247.9B | $259.8B | $224.8B | $236.3B | $238.5B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $126M | $62M | -- | -- | -- | |
| Long-Term Debt | $3.4B | $3.2B | $3.2B | $3.2B | $3.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $229.8B | $243.6B | $219.2B | $231.3B | $233.5B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | |
| Other Common Equity Adj | $5.7B | $4.2B | -$6.1B | -$5.2B | -$5.3B | |
| Common Equity | $18B | $16.1B | $5.5B | $4.9B | $5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $65M | $65M | $65M | $65M | $65M | |
| Total Equity | $18.1B | $16.2B | $5.6B | $5B | $5B | |
| Total Liabilities and Equity | $247.9B | $259.8B | $224.8B | $236.3B | $238.5B | |
| Cash and Short Terms | $89.8B | $93.9B | $80.8B | $86B | $87B | |
| Total Debt | $3.4B | $3.2B | $3.2B | $3.2B | $3.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.1B | $4.5B | $4.1B | $3.9B | $5B | |
| Short Term Investments | $85.7B | $89.4B | $76.7B | $82.2B | $81.9B | |
| Accounts Receivable, Net | $16.2B | $16.1B | $18.5B | $19.8B | $21.1B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $106B | $110B | $99.4B | $105.8B | $108.1B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $88.7B | $93.8B | $81.5B | $87.2B | $86.8B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $504M | $530M | $459M | $416M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $247.9B | $259.8B | $224.8B | $236.3B | $238.5B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $126M | $62M | -- | -- | -- | |
| Long-Term Debt | $3.4B | $3.2B | $3.2B | $3.2B | $3.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $229.8B | $243.6B | $219.2B | $231.3B | $233.5B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | |
| Other Common Equity Adj | $5.7B | $4.2B | -$6.1B | -$5.2B | -$5.3B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | $558M | -- | -- | -- | -- | |
| Minority Interest, Total | $65M | $65M | $65M | $65M | $65M | |
| Total Equity | $18.1B | $16.2B | $5.6B | $5B | $5B | |
| Total Liabilities and Equity | $247.9B | $259.8B | $224.8B | $236.3B | $238.5B | |
| Cash and Short Terms | $89.8B | $93.9B | $80.8B | $86B | $87B | |
| Total Debt | $3.4B | $3.2B | $3.2B | $3.2B | $3.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.1B | $1.6B | $3.9B | -$1.1B | $393M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$1.3B | $495M | -$1.4B | -$1.3B | -$1.5B | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $888M | $641M | -$1.2B | -$137M | -$290M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$404M | -$566M | -$562M | -$248M | $38M | |
| Cash From Investing | -$5.8B | -$12.2B | -$8.3B | -$3.2B | -$2.2B | |
| Dividends Paid (Ex Special Dividend) | -$44M | -$89M | -$104M | -$102M | -$102M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $615M | $400M | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.6B | -$680M | -$3M | -$2M | -$2M | |
| Repurchase of Common Stock | -$473M | -$499M | -$488M | -$250M | -$250M | |
| Other Financing Activities | $5.8B | $11.5B | $11.4B | $4.3B | $3.8B | |
| Cash From Financing | $6.2B | $12B | $9.1B | $3.1B | $3.7B | |
| Beginning Cash (CF) | $2.9B | $4.1B | $4.5B | $4.1B | $3.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.2B | $366M | -$359M | -$264M | $1.2B | |
| Ending Cash (CF) | $4.1B | $4.5B | $4.1B | $3.9B | $5B | |
| Levered Free Cash Flow | $888M | $641M | -$1.2B | -$137M | -$290M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $373M | -$3M | -$226M | $152M | -$118M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$105M | -$174M | -$123M | -$48M | $27M | |
| Cash From Investing | -$1.7B | -$2.6B | -$680M | -$552M | -$357M | |
| Dividends Paid (Ex Special Dividend) | -$13M | -$21M | -$26M | -$25M | -$25M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$551M | -$679M | -$1M | -$1M | -$1M | |
| Repurchase of Common Stock | -$97M | -$158M | -$93M | -$60M | -$60M | |
| Other Financing Activities | $1B | $2.4B | $2.3B | $769M | -$151M | |
| Cash From Financing | -$795M | $2.9B | $228M | $412M | -$110M | |
| Beginning Cash (CF) | $6.2B | $4.1B | $4.8B | $3.8B | $5.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2.1B | $366M | -$678M | $12M | -$585M | |
| Ending Cash (CF) | $4.1B | $4.5B | $4.1B | $3.9B | $5B | |
| Levered Free Cash Flow | $373M | -$3M | -$226M | $152M | -$118M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $888M | $641M | -$1.2B | -$137M | -$290M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$404M | -$566M | -$562M | -$248M | $38M | |
| Cash From Investing | -$5.8B | -$12.2B | -$8.3B | -$3.2B | -$2.2B | |
| Dividends Paid (Ex Special Dividend) | -$44M | -$89M | -$104M | -$102M | -$102M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$680M | -$3M | -- | -- | |
| Repurchase of Common Stock | -$473M | -$499M | -$488M | -$250M | -$250M | |
| Other Financing Activities | $5.8B | $11.5B | $11.4B | $4.3B | $3.8B | |
| Cash From Financing | $6.2B | $12B | $9.1B | $3.1B | $3.7B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.2B | $366M | -$359M | -$264M | $1.2B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $888M | $641M | -$1.2B | -$137M | -$290M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $641M | -$1.2B | -$137M | -$290M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$566M | -$562M | -$248M | $38M | -- | |
| Cash From Investing | -$12.2B | -$8.3B | -$3.2B | -$2.2B | -- | |
| Dividends Paid (Ex Special Dividend) | -$89M | -$104M | -$102M | -$102M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$680M | -$3M | -$2M | -$2M | -- | |
| Repurchase of Common Stock | -$499M | -$488M | -$250M | -$250M | -- | |
| Other Financing Activities | $11.5B | $11.4B | $4.3B | $3.8B | -- | |
| Cash From Financing | $12B | $9.1B | $3.1B | $3.7B | -- | |
| Beginning Cash (CF) | $17.1B | $18.4B | $15.4B | $17.7B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $366M | -$359M | -$264M | $1.2B | -- | |
| Ending Cash (CF) | $17.5B | $18.1B | $15.1B | $18.9B | -- | |
| Levered Free Cash Flow | $641M | -$1.2B | -$137M | -$290M | -- | |
Get BHF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BHF
Sector
P/E ratio
11.24x
11.41x
PEG ratio
0.00x
0.38x
P/B ratio
0.68x
1.07x
Price / LTM sales
--
2.51x
Growth Metrics
BHF
Sector
Revenue growth
-20.93%
6.9%
Earnings growth
-64.15%
6.98%
Revenue (5-year growth)
-7.14%
5.22%
Earnings forecast
$4.31
$0.56
Profitability
BHF
Sector
Profitability FY 2024
--
$161.4M
Return on invested capital
4.87%
5.53%
Return on assets
0.16%
0.99%
Return on equity
8.05%
9.5%
Earnings Date
Last Earnings Date
Feb
11
Next Earnings Date
May
7
Estimated Next Earnings Date
May
13
Balance Sheet
BHF
Sector
Total cash
$87B
$485.1M
Short term investments
$81.9B
$263.9M
Total assets
$238.5B
$4.5B
Long term debt
$3.2B
$327.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
